Amr R. Ibrahim, Richard E. Clark, Tessa L. Holyoake, Jenny Byrne, Pat Shepherd, Jane F. Apperley, Dragana Milojkovic, Richard Szydlo, John Goldman, and David Marin. 2011. “Second-Generation Tyrosine Kinase Inhibitors Improve the Survival of Patients With Chronic Myeloid Leukemia in Whom Imatinib Therapy Has Failed”. Haematologica 96 (12). Pavia, Italy, 1779-82. https://doi.org/10.3324/haematol.2011.049759.